glp 1 agonist vs bariatric surgery Unique and Shared Effects of and GLP-1RA Bariatric Surgery vs GLP-1 Medications
Description
The brain response GLP-1 crosses the blood-brain barrier through passive diffusion and receptor-mediated transcytosis
Patients with Significant Liver Involvement: Those diagnosed with hepatic steatosis (fatty liver) or early-stage MASH, due to the potent anti-fat effects of the glucagon component on the liver
As the body of literature on this topic expands, more refined clinical guidance for the use of GLP-1RAs is expected to emerge
A recent post-hoc analysis of SURPASS-3 (NCT03882970) in adults with T2DM reported decreases in fat mass and muscle fat infiltration (MFI) accompanying weight loss [65], suggesting potential improvements in muscle quality that may be especially promising for older adults
Gastric bypass surgery attenuates ethanol consumption in ethanol-preferring rats
